Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The present study was a randomized, open-label, two-period, two-sequence, cross-over study,
conducted to find out whether the etoricoxib 120 mg film-coated tablet produced by PT Dexa
Medica (test drug) was bioequivalent to the reference drug (Arcoxia® Film-Coated Tablet 120
mg, PT. Schering-Plough Indonesia Tbk), under fasting condition with a fourteen days wash-out
period, involving 26 healthy adult male and female subjects.